Current Ratio of PharmaCyte Biotech, Inc. from 31 Jan 2012 to 31 Jan 2026
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
PharmaCyte Biotech, Inc. quarterly Current Ratio in x history and change rate from 31 Jan 2012 to 31 Jan 2026.
- PharmaCyte Biotech, Inc. Current Ratio for the quarter ending 31 Jan 2026 was 11.78x, a 102% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
PharmaCyte Biotech, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 11.78x | +5.95x | +102% | 31 Jan 2026 |
| Q3 2025 | 12.07x | +5.97x | +98% | 31 Oct 2025 |
| Q2 2025 | 8.02x | +0.12x | +1.6% | 31 Jul 2025 |
| Q1 2025 | 5.72x | -6.27x | -52% | 30 Apr 2025 |
| Q4 2024 | 5.83x | -12.86x | -69% | 31 Jan 2025 |
| Q3 2024 | 6.11x | -29.32x | -83% | 31 Oct 2024 |
| Q2 2024 | 7.9x | -61.13x | -89% | 31 Jul 2024 |
| Q1 2024 | 11.99x | -66.76x | -85% | 30 Apr 2024 |
| Q4 2023 | 18.69x | -62.12x | -77% | 31 Jan 2024 |
| Q3 2023 | 35.42x | -53.82x | -60% | 31 Oct 2023 |
| Q2 2023 | 69.03x | -62.77x | -48% | 31 Jul 2023 |
| Q1 2023 | 78.76x | -28.72x | -27% | 30 Apr 2023 |
| Q4 2022 | 80.81x | +8.21x | +11% | 31 Jan 2023 |
| Q3 2022 | 89.24x | +51.24x | +135% | 31 Oct 2022 |
| Q2 2022 | 131.8x | +128.15x | +3504% | 31 Jul 2022 |
| Q1 2022 | 107.48x | +103.83x | +2849% | 30 Apr 2022 |
| Q4 2021 | 72.6x | +69.63x | +2348% | 31 Jan 2022 |
| Q3 2021 | 38x | +36.09x | +1886% | 31 Oct 2021 |
| Q2 2021 | 3.66x | +2.72x | +290% | 31 Jul 2021 |
| Q1 2021 | 3.64x | +3.09x | +552% | 30 Apr 2021 |
| Q4 2020 | 2.97x | +2.48x | +507% | 31 Jan 2021 |
| Q3 2020 | 1.91x | +1.13x | +145% | 31 Oct 2020 |
| Q2 2020 | 0.94x | -0.18x | -16% | 31 Jul 2020 |
| Q1 2020 | 0.56x | -0.98x | -64% | 30 Apr 2020 |
| Q4 2019 | 0.49x | -1.35x | -73% | 31 Jan 2020 |
| Q3 2019 | 0.78x | -1.1x | -58% | 31 Oct 2019 |
| Q2 2019 | 1.12x | -1.44x | -56% | 31 Jul 2019 |
| Q1 2019 | 1.54x | -1.85x | -55% | 30 Apr 2019 |
| Q4 2018 | 1.83x | -2.41x | -57% | 31 Jan 2019 |
| Q3 2018 | 1.88x | -3.22x | -63% | 31 Oct 2018 |
| Q2 2018 | 2.56x | -2.31x | -47% | 31 Jul 2018 |
| Q1 2018 | 3.39x | -1.46x | -30% | 30 Apr 2018 |
| Q4 2017 | 4.25x | +0.23x | +5.8% | 31 Jan 2018 |
| Q3 2017 | 5.1x | +1.68x | +49% | 31 Oct 2017 |
| Q2 2017 | 4.86x | +1.73x | +55% | 31 Jul 2017 |
| Q1 2017 | 4.86x | +1.91x | +65% | 30 Apr 2017 |
| Q4 2016 | 4.01x | +1.16x | +41% | 31 Jan 2017 |
| Q3 2016 | 3.41x | +0.54x | +19% | 31 Oct 2016 |
| Q2 2016 | 3.13x | +0.04x | +1.3% | 31 Jul 2016 |
| Q1 2016 | 2.95x | -0.79x | -21% | 30 Apr 2016 |
| Q4 2015 | 2.85x | -3.96x | -58% | 31 Jan 2016 |
| Q3 2015 | 2.87x | -3.84x | -57% | 31 Oct 2015 |
| Q2 2015 | 3.09x | -1.09x | -26% | 31 Jul 2015 |
| Q1 2015 | 3.74x | +0.91x | +32% | 30 Apr 2015 |
| Q4 2014 | 6.81x | +5.9x | +652% | 31 Jan 2015 |
| Q3 2014 | 6.71x | +6.12x | +1036% | 31 Oct 2014 |
| Q2 2014 | 4.18x | +3.65x | +683% | 31 Jul 2014 |
| Q1 2014 | 2.82x | +2.43x | +631% | 30 Apr 2014 |
| Q4 2013 | 0.9x | +0.57x | +171% | 31 Jan 2014 |
| Q3 2013 | 0.59x | +0.3x | +100% | 31 Oct 2013 |
| Q2 2013 | 0.53x | +0.29x | +116% | 31 Jul 2013 |
| Q1 2013 | 0.39x | +0.18x | +88% | 30 Apr 2013 |
| Q4 2012 | 0.33x | +0.19x | +137% | 31 Jan 2013 |
| Q3 2012 | 0.29x | 31 Oct 2012 | ||
| Q2 2012 | 0.25x | 31 Jul 2012 | ||
| Q1 2012 | 0.2x | 30 Apr 2012 | ||
| Q4 2011 | 0.14x | 31 Jan 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.